E-cadherin inhibits the proliferation and migration of human colorectal cancer cells through Hippo signaling pathway
European Journal of Histochemistry · 26.05.2025 · 69 (2)
DOI: 10.4081/ejh.2025.4196 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Histochemistry, online erschienen am 26.05.2025. Verfasst von Zhijing Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Qingxiu District, Nanning City, Guangxi…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Cell Proliferation, Protein Serine-Threonine Kinases, Cadherins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
E-cadherin (E-cad) is a crucial regulatory factor in rescue Epithelial-mesenchymal transition and is involved in the occurrence of various malignant tumor. However, the mechanisms by which E-cadherin regulates tumor metastasis in CRC remain unclear. We established sh-E-cad (silenced by short hairpin RNA) and rescue-E-cad (overexpressed by E-cad plasmid transfection) CRC cell lines to investigate the role of E-cad in CRC in vitro. Immunohistochemistry, clonogenic assays, scratch wound healing assays, CCK-8 assays, flow cytometry, Transwell assay, real time-PCR and Western blot were employed to investigate the underlying mechanisms by which E-cad involve the progression of CRC. In CRC tissues, E-cad expression was significantly reduced, while YAP expression was markedly elevated. Silencing E-cad induced a significant increase of clonogenic ability in CRC cells, which was reduced upon rescue of E-cad expression. Transwell assays indicate that low expression of E-cad enhances the cell migration, a finding corroborated by scratch wound healing experiments. CCK-8 results demonstrate that silencing E-cad promotes the proliferation of CRC cells. Importantly, we found that E-cad influences apoptosis rather than the cell cycle. Analysis of Hippo signaling pathway-related factors revealed that silencing E-cad resulted in significantly decreased expression of MST1/2 and LATS1/2, as well as reduced phosphorylation levels of YAP, while YAP expression was significantly increased. Additionally, immunofluorescence confirmed the nuclear translocation of YAP. Our study indicates that E-cad regulates the malignant progression of CRC via the Hippo signaling pathway, offering a potential new strategy for CRC treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region.
- School of Basic Science, Guangxi University of Traditional Chinese Medicine, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region.
Zitieren
APA
Wang, Z., Qin, X., Liu, S., Wen, Y., Lan, B., Liao, H., & Wei, H. (2025). E-cadherin inhibits the proliferation and migration of human colorectal cancer cells through Hippo signaling pathway. European Journal of Histochemistry, 69(2). https://doi.org/10.4081/ejh.2025.4196
Vancouver
Wang Z, Qin X, Liu S, Wen Y, Lan B, Liao H, et al. E-cadherin inhibits the proliferation and migration of human colorectal cancer cells through Hippo signaling pathway. European Journal of Histochemistry. 2025;69(2). doi:10.4081/ejh.2025.4196
BibTeX
@article{Wang2025,
author = {Wang, Zhijing and Qin, Xiaohua and Liu, Shanshan and Wen, Yilei and Lan, Bikan and Liao, Hantao and Wei, Haixian},
title = {E-cadherin inhibits the proliferation and migration of human colorectal cancer cells through Hippo signaling pathway},
journal = {European Journal of Histochemistry},
year = {2025},
volume = {69},
number = {2},
doi = {10.4081/ejh.2025.4196}
}
EUVIMED